10x Genomics, Inc. Peer Comparison
Metric | Value | Ranking | ||||||
---|---|---|---|---|---|---|---|---|
Market Cap | $1.4 Billion | 5/6 | GH $5.6B |
VCYT $3.2B |
TWST $2.8B |
BEAM $2.4B |
TXG $1.4B |
FATE $142.4M |
Gross Margin | 70% | 3/6 | FATE 100% |
GH 100% |
TXG 70% |
VCYT 68% |
BEAM 62% |
TWST 45% |
Profit Margin | -24% | 2/6 | VCYT 13% |
TXG -24% |
TWST -41% |
GH -56% |
FATE -100% |
BEAM -100% |
EBITDA margin | -16% | 2/6 | VCYT 10% |
TXG -16% |
TWST -43% |
GH -61% |
BEAM -639% |
FATE -1704% |
Quarterly Revenue | $151.7 Million | 2/6 | GH $191.5M |
TXG $151.7M |
VCYT $115.9M |
TWST $84.7M |
BEAM $14.3M |
FATE $3.1M |
Quarterly Earnings | -$35.8 Million | 3/6 | VCYT $15.2M |
TWST -$34.7M |
TXG -$35.8M |
FATE -$47.7M |
BEAM -$96.7M |
GH -$107.8M |
Quarterly Free Cash Flow | $17.8 Million | 2/6 | VCYT $27.7M |
TXG $17.8M |
FATE -$29.9M |
GH -$55.3M |
BEAM -$89.7M |
TWST -$0 |
Trailing 4 Quarters Revenue | $629.7 Million | 2/6 | GH $692.3M |
TXG $629.7M |
BEAM $349.6M |
VCYT $327.1M |
TWST $313.0M |
FATE $13.4M |
Trailing 4 Quarters Earnings | -$182.6 Million | 3/6 | GH $191.5M |
TXG $151.7M |
VCYT $115.9M |
TWST $84.7M |
BEAM $14.3M |
FATE $3.1M |
Quarterly Earnings Growth | 62% | 2/6 | VCYT 280% |
TXG 62% |
TWST 25% |
BEAM -1% |
FATE -6% |
GH -25% |
Annual Earnings Growth | 35% | 3/6 | VCYT 175% |
BEAM 58% |
TXG 35% |
FATE 8% |
TWST 4% |
GH -68% |
Quarterly Revenue Growth | -1% | 5/6 | FATE 58% |
GH 34% |
VCYT 28% |
TWST 27% |
TXG -1% |
BEAM -17% |
Annual Revenue Growth | 6% | 5/6 | BEAM 351% |
FATE 184% |
GH 25% |
TWST 21% |
TXG 6% |
VCYT -3% |
Cash On Hand | $398.2 Million | 2/6 | GH $688.4M |
TXG $398.2M |
VCYT $274.1M |
BEAM $230.2M |
TWST $226.3M |
FATE $37.9M |
Short Term Debt | $9.4 Million | 3/6 | TWST $14.8M |
BEAM $12.9M |
TXG $9.4M |
VCYT $7.3M |
FATE $6.9M |
GH -$0 |
Long Term Debt | $76.5 Million | 4/6 | GH $1.3B |
BEAM $298.3M |
FATE $92.1M |
TXG $76.5M |
TWST $70.2M |
VCYT $12.4M |
PE | -1.00 | 2/6 | VCYT 166.89 |
TXG -1.00 |
FATE -1.00 |
GH -1.00 |
TWST -1.00 |
BEAM -1.00 |
PS | 2.27 | 6/6 | FATE 10.59 |
VCYT 9.71 |
TWST 8.81 |
GH 8.10 |
BEAM 6.77 |
TXG 2.27 |
PB | 1.98 | 4/6 | TWST 5.83 |
BEAM 2.99 |
VCYT 2.70 |
TXG 1.98 |
FATE 0.39 |
GH 0.00 |
PC | 3.59 | 6/6 | TWST 12.18 |
VCYT 11.58 |
BEAM 10.28 |
GH 8.15 |
FATE 3.76 |
TXG 3.59 |
Liabilities to Equity | 0.30 | 3/6 | BEAM 0.48 |
FATE 0.37 |
TXG 0.30 |
TWST 0.30 |
VCYT 0.08 |
GH 0.00 |
ROA | -0.19 | 3/6 | VCYT 1% | BEAM -12% | TXG -19% | GH -33% | TWST -34% | FATE -38% |
ROE | -0.25 | 4/6 | GH 853% |
VCYT 2% |
BEAM -18% |
TXG -25% |
TWST -44% |
FATE -52% |
Current Ratio | 4.36 | 2/6 | VCYT 12.88 |
TXG 4.36 |
TWST 4.34 |
FATE 3.73 |
BEAM 3.08 |
GH 0.96 |
Quick Ratio | 1.85 | 5/6 | VCYT 166.89 |
TXG -1.00 |
FATE -1.00 |
GH -1.00 |
TWST -1.00 |
BEAM -1.00 |
Long Term Debt to Equity | 0.11 | 4/6 | BEAM} 0.38 |
FATE} 0.25 |
TWST} 0.15 |
TXG} 0.11 |
VCYT} 0.01 |
GH} -21.83 |
Debt to Equity | 0.12 | 4/6 | FATE 0.27 |
BEAM 0.20 |
TWST 0.18 |
TXG 0.12 |
VCYT 0.02 |
GH -21.83 |
Burn Rate | 9.67 | 1/6 | TXG 9.67 |
TWST 5.50 |
GH 4.30 |
BEAM 2.06 |
FATE 0.71 |
VCYT -21.35 |
Cash to Cap | 0.28 | 1/6 | TXG 0.28 |
FATE 0.27 |
GH 0.12 |
BEAM 0.10 |
VCYT 0.09 |
TWST 0.08 |
CCR | -0.50 | 5/6 | VCYT 1.83 |
BEAM 0.93 |
FATE 0.63 |
GH 0.51 |
TXG -0.50 |
TWST |
EV to EBITDA | -47.23 | 4/6 | VCYT} 243.05 |
FATE} -3.88 |
BEAM} -25.20 |
TXG} -47.23 |
GH} -53.10 |
TWST} -72.54 |
EV to Revenue | 1.78 | 6/6 | FATE 15.13 |
GH 9.00 |
VCYT 8.93 |
TWST 8.35 |
BEAM 6.57 |
TXG 1.78 |